Materne 1985.
Methods | RCT, parallel design | |
Participants |
Total number of randomized participants: 71 Inclusion criteria: elective CABG Exclusion criteria: left ventricular ejection fraction < 40%, previous treatment with amiodarone, major perioperative complication (MI, cardiac tamponade), use of another anti‐arrhythmic drug Type of surgery: elective CABG Baseline characteristics (acebutolol) Intervention group
Control group (standard care)
Country: Belgium Setting: single centre; hospital |
|
Interventions |
Intervention group (acebutolol)
Control group (standard care)
|
|
Outcomes |
Outcomes measured/reported by study authors: supraventricular arrhythmias (to include AF), ventricular extrasystoles, haemodynamic parameters Outcomes relevant to the review: AF |
|
Notes |
Funding/declarations of interest: not reported Study dates: not reported |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not specified |
Allocation concealment (selection bias) | Unclear risk | Not specified |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Open‐label trial |
Blinding of outcome assessors (detection bias) All outcomes | High risk | Open‐label trial |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No apparent losses |
Selective reporting (reporting bias) | Unclear risk | Study authors did not report prospective clinical trial registration or publication of a protocol. It was not feasible to effectively assess risk of reporting bias |
Other bias | Low risk | Not detected |